Cyclo Therapeutics (NASDAQ:CYTH – Get Rating) is one of 41 publicly-traded companies in the “Industrial organic chemicals” industry, but how does it compare to its peers? We will compare Cyclo Therapeutics to similar companies based on the strength of its dividends, institutional ownership, profitability, earnings, risk, valuation and analyst recommendations. Institutional & Insider Ownership 5.2% […]